Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Oral Semaglutide.

Hughes S, Neumiller JJ.

Clin Diabetes. 2020 Jan;38(1):109-111. doi: 10.2337/cd19-0079. No abstract available.

PMID:
31975761
2.

Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry.

Tuttle KR, Alicic RZ, Duru OK, Jones CR, Daratha KB, Nicholas SB, McPherson SM, Neumiller JJ, Bell DS, Mangione CM, Norris KC.

JAMA Netw Open. 2019 Dec 2;2(12):e1918169. doi: 10.1001/jamanetworkopen.2019.18169.

3.

Liberalisation, deintensification, and simplification in diabetes management: words matter.

Munshi M, Neumiller JJ.

Lancet Diabetes Endocrinol. 2020 Feb;8(2):95-97. doi: 10.1016/S2213-8587(19)30379-1. Epub 2019 Nov 25. No abstract available.

PMID:
31780376
4.

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD.

Norris KC, Duru OK, Alicic RZ, Daratha KB, Nicholas SB, McPherson SM, Bell DS, Shen JI, Jones CR, Moin T, Waterman AD, Neumiller JJ, Vargas RB, Bui AAT, Mangione CM, Tuttle KR; CURE-CKD investigators.

BMC Nephrol. 2019 Nov 20;20(1):416. doi: 10.1186/s12882-019-1558-9.

5.

Assessment of Regular and NPH Insulin Concentration via Two Methods of Quantification: The Washington State Insulin Concentration Study (WICS).

Neumiller JJ, Chen G, Newsome C, Hughes S, Lazarus P, White JR Jr.

J Diabetes Sci Technol. 2019 Oct 22:1932296819883291. doi: 10.1177/1932296819883291. [Epub ahead of print]

PMID:
31640422
6.

How Does CREDENCE Inform Best Use of SGLT2 Inhibitors in CKD?

Neumiller JJ, Kalyani RR.

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1667-1669. doi: 10.2215/CJN.05340419. Epub 2019 Oct 1. No abstract available.

PMID:
31575617
7.

Potential Adverse Drug Events and Associated Costs During Transition from Hospital to Home.

Neumiller JJ, Mandal B, Weeks DL, Bautista E, Gates BJ, Corbett CF.

Sr Care Pharm. 2019 Jun 1;34(6):384-392. doi: 10.4140/TCP.n.2019.384.

PMID:
31164185
8.

Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions.

Perreault L, Vincent L, Neumiller JJ, Santos-Cavaiola T.

J Am Board Fam Med. 2019 May-Jun;32(3):431-447. doi: 10.3122/jabfm.2019.03.180162. Review.

9.

Evidence supports prediabetes treatment.

Neumiller JJ, Kalyani RR, Herman WH, Grant RW, Wysham CH, Inzucchi SE, Hirsch IB, Fonseca VA, Buse JB, Barrett EJ.

Science. 2019 Apr 26;364(6438):341-342. doi: 10.1126/science.aax3548. No abstract available.

PMID:
31023917
10.

Erratum. Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248-257.

Alicic RZ, Neumiller JJ, Johnson EJ, Dieter B, Tuttle KR.

Diabetes. 2019 May;68(5):1094. doi: 10.2337/db19-er05a. Epub 2019 Apr 1. No abstract available.

11.

Medtronic MiniMed 670G Hybrid Closed-Loop System.

Knebel T, Neumiller JJ.

Clin Diabetes. 2019 Jan;37(1):94-95. doi: 10.2337/cd18-0067. No abstract available.

12.

Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease.

Alicic RZ, Neumiller JJ, Johnson EJ, Dieter B, Tuttle KR.

Diabetes. 2019 Feb;68(2):248-257. doi: 10.2337/dbi18-0007. Review. Erratum in: Diabetes. 2019 May;68(5):1094.

13.

Diabetes Spectrum: Past, Present, and Future.

Neumiller JJ.

Diabetes Spectr. 2018 Nov;31(4):297-298. doi: 10.2337/ds18-0051. No abstract available.

14.

Oral Semaglutide.

Bui V, Neumiller JJ.

Clin Diabetes. 2018 Oct;36(4):327-329. doi: 10.2337/cd18-0034. No abstract available.

15.

2018 Standards of Care Update: Pharmacologic Approaches to Glycemic Management in People With Type 2 Diabetes.

Neumiller JJ, Umpierrez GE.

Diabetes Spectr. 2018 Aug;31(3):254-260. doi: 10.2337/ds18-0030.

16.

Pearls for Your Practice: A Clinician's Guide to Recently Published Guidelines and Position Statements.

Umpierrez GE, Neumiller JJ.

Diabetes Spectr. 2018 Aug;31(3):215-216. doi: 10.2337/ds18-0042. No abstract available.

17.

Medication Therapy Management after Hospitalization in CKD: A Randomized Clinical Trial.

Tuttle KR, Alicic RZ, Short RA, Neumiller JJ, Gates BJ, Daratha KB, Barbosa-Leiker C, McPherson SM, Chaytor NS, Dieter BP, Setter SM, Corbett CF.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):231-241. doi: 10.2215/CJN.06790617. Epub 2018 Jan 2.

18.

Will Canagliflozin Lend Credence to the Potential Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Renal Endpoints in Diabetic Nephropathy.

Neumiller JJ, Rhee CM, Kalantar-Zadeh K.

Am J Nephrol. 2017;46(6):459-461. doi: 10.1159/000484669. Epub 2017 Dec 11. No abstract available.

19.

Therapeutic Considerations for Antihyperglycemic Agents in Diabetic Kidney Disease.

Neumiller JJ, Alicic RZ, Tuttle KR.

J Am Soc Nephrol. 2017 Aug;28(8):2263-2274. doi: 10.1681/ASN.2016121372. Epub 2017 May 2. Review.

20.

2016 Prescott Lecture: Diabetes education-leadership through action.

Neumiller JJ.

J Am Pharm Assoc (2003). 2016 Nov - Dec;56(6):611-614. doi: 10.1016/j.japh.2016.08.016. No abstract available.

PMID:
27836122
21.

Preserving Self: Medication-Taking Practices and Preferences of Older Adults With Multiple Chronic Medical Conditions.

Vandermause R, Neumiller JJ, Gates BJ, David P, Altman M, Healey DJ, Benson P, Sunwold D, Burton G, Tuttle KR, Corbett CF.

J Nurs Scholarsh. 2016 Nov;48(6):533-542. doi: 10.1111/jnu.12250.

PMID:
27802372
22.

Medication Intervention for Chronic Kidney Disease Patients Transitioning from Hospital to Home: Study Design and Baseline Characteristics.

Alicic RZ, Short RA, Corbett CL, Neumiller JJ, Gates BJ, Daratha KB, Barbosa-Leiker C, McPherson S, Chaytor NS, Dieter BP, Setter SM, Tuttle KR.

Am J Nephrol. 2016;44(2):122-9. doi: 10.1159/000447019. Epub 2016 Aug 4.

23.

Prandial Insulin Dosing: How Long Does It Take to Go 80 Miles?

Mystkowski P, Neumiller JJ.

Diabetes Spectr. 2016 May;29(2):67-9. doi: 10.2337/diaspect.29.2.67. No abstract available. Erratum in: Diabetes Spectr. 2016 Aug;29(3):192.

24.

Alogliptin + metformin combination for the treatment of type 2 diabetes mellitus.

Neumiller JJ, Holland DQ.

Expert Rev Endocrinol Metab. 2016 Jan;11(1):21-31. doi: 10.1586/17446651.2016.1110484. Epub 2015 Nov 18.

PMID:
30063448
25.

Management of Hyperglycemia in Diabetic Kidney Disease.

Neumiller JJ, Hirsch IB.

Diabetes Spectr. 2015 Aug;28(3):214-9. doi: 10.2337/diaspect.28.3.214. No abstract available.

26.

Efficacy and safety of saxagliptin as add-on therapy in type 2 diabetes.

Neumiller JJ.

Clin Diabetes. 2014 Oct;32(4):170-7. doi: 10.2337/diaclin.32.4.170.

27.

Incretin-based therapies.

Neumiller JJ.

Med Clin North Am. 2015 Jan;99(1):107-29. doi: 10.1016/j.mcna.2014.08.013. Epub 2014 Oct 18. Review.

PMID:
25456646
28.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
29.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

30.

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus.

Holland DQ, Neumiller JJ.

Diabetes Metab Syndr Obes. 2014 Jul 3;7:277-88. doi: 10.2147/DMSO.S37648. eCollection 2014. Review.

31.

Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.

Neumiller JJ.

Drugs Context. 2014 Jun 11;3:212262. doi: 10.7573/dic.212262. eCollection 2014. Review.

32.

Response to comments on Evert et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care 2013;36:3821-3842.

Yancy WS Jr, Dunbar SA, Boucher JL, Cypress M, Evert AB, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Urbanski P, Verdi CL, Nwankwo R.

Diabetes Care. 2014 May;37(5):e102-3. doi: 10.2337/dc14-0077. No abstract available.

PMID:
24757235
33.

Postoperative delirium in Parkinson's disease patients following deep brain stimulation surgery.

Carlson JD, Neumiller JJ, Swain LD, Mark J, McLeod P, Hirschauer J.

J Clin Neurosci. 2014 Jul;21(7):1192-5. doi: 10.1016/j.jocn.2013.12.007. Epub 2014 Jan 2.

PMID:
24518269
34.

Calling All Educators: Let Us Know Your Educational Needs.

Neumiller JJ.

Diabetes Spectr. 2014 Feb;27(1):3-4. doi: 10.2337/diaspect.27.1.3. No abstract available.

35.

Nutrition therapy recommendations for the management of adults with diabetes.

Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr.

Diabetes Care. 2014 Jan;37 Suppl 1:S120-43. doi: 10.2337/dc14-S120. Review. No abstract available.

PMID:
24357208
36.

Nutrition therapy recommendations for the management of adults with diabetes.

Evert AB, Boucher JL, Cypress M, Dunbar SA, Franz MJ, Mayer-Davis EJ, Neumiller JJ, Nwankwo R, Verdi CL, Urbanski P, Yancy WS Jr; American Diabetes Association.

Diabetes Care. 2013 Nov;36(11):3821-42. doi: 10.2337/dc13-2042. Epub 2013 Oct 9.

37.

National Diabetes Month 2012. Updated treatment guidelines or type 2 diabete.

Neumiller JJ, To S.

Diabetes Self Manag. 2012 Nov-Dec;29(6):10, 12, 15. No abstract available.

PMID:
23330468
38.

Can a new ultra-long-acting insulin analogue improve patient care? Investigating the potential role of insulin degludec.

Robinson JD, Neumiller JJ, Campbell RK.

Drugs. 2012 Dec 24;72(18):2319-25. doi: 10.2165/11642240-000000000-00000. Review.

PMID:
23145524
39.

Incretin pharmacology: a review of the incretin effect and current incretin-based therapies.

Neumiller JJ.

Cardiovasc Hematol Agents Med Chem. 2012 Dec;10(4):276-88. Review.

PMID:
22827291
40.

Review of linagliptin for the treatment of type 2 diabetes mellitus.

Neumiller JJ, Setter SM.

Clin Ther. 2012 May;34(5):993-1005. doi: 10.1016/j.clinthera.2012.02.029. Epub 2012 Mar 21. Review.

PMID:
22440191
41.

Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus.

Neumiller JJ.

Ann Pharmacother. 2012 Mar;46(3):358-67. doi: 10.1345/aph.1Q522. Epub 2012 Feb 7. Review.

PMID:
22318932
42.

Transitional care: exploring the home healthcare nurse's role in medication management.

Setter SM, Corbett CF, Neumiller JJ.

Home Healthc Nurse. 2012 Jan;30(1):19-26. doi: 10.1097/NHH.0b013e31823aa8c8.

PMID:
22173616
43.

Treating type 2 diabetes: a growing number of options.

Neumiller JJ, To S.

Diabetes Self Manag. 2011 Jul-Aug;28(4):38, 40-2. Review. No abstract available.

PMID:
21848053
44.

Clinical pharmacology of incretin therapies for type 2 diabetes mellitus: implications for treatment.

Neumiller JJ.

Clin Ther. 2011 May;33(5):528-76. doi: 10.1016/j.clinthera.2011.04.024. Review.

PMID:
21665041
45.

Challenges of medication management in hospitalized patients with Parkinson's disease.

Wood LD, Neumiller JJ, Carlson J, Setter SM, Corbett CF.

Am J Health Syst Pharm. 2010 Dec 1;67(23):2059-63. doi: 10.2146/ajhp100170. No abstract available.

PMID:
21098379
46.

Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease.

Wood LD, Neumiller JJ, Setter SM, Dobbins EK.

Am J Geriatr Pharmacother. 2010 Aug;8(4):294-315. doi: 10.1016/j.amjopharm.2010.08.002. Review.

PMID:
20869620
47.

Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus.

Neumiller JJ, Campbell RK.

Am J Health Syst Pharm. 2010 Sep 15;67(18):1515-25. doi: 10.2146/ajhp090555. Review.

PMID:
20811029
48.

Managing your medicines. Tips and tools that can help.

Neumiller JJ.

Diabetes Self Manag. 2010 Jul-Aug;27(4):38, 40-2. No abstract available.

PMID:
20707244
49.

Nurse identified hospital to home medication discrepancies: implications for improving transitional care.

Corbett CF, Setter SM, Daratha KB, Neumiller JJ, Wood LD.

Geriatr Nurs. 2010 May-Jun;31(3):188-96. doi: 10.1016/j.gerinurse.2010.03.006.

PMID:
20525523
50.

A review of inhaled technosphere insulin.

Neumiller JJ, Campbell RK, Wood LD.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1231-9. doi: 10.1345/aph.1P055. Epub 2010 Jun 1. Review.

PMID:
20516362

Supplemental Content

Loading ...
Support Center